High‐ and intermediate‐risk susceptibility variants in melanoma families from the Mediterranean area: A multicentre cohort from the MelaNostrum Consortium
Journal of the European Academy of Dermatology and Venereology · 2023
DOI: 10.1111/jdv.19461 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2023. Verfasst von C Pellegrini und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy. Hauptthemen laut MEDLINE: Skin Neoplasms, Melanoma. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, Intramural NIH HHS, European Regional Development Fund.
Abstract (Originalsprache)
Background
Most of large epidemiological studies on melanoma susceptibility have been conducted on fair skinned individuals (US, Australia and Northern Europe), while Southern European populations, characterized by high UV exposure and dark‐skinned individuals, are underrepresented.
Objectives
We report a comprehensive pooled analysis of established high‐ and intermediate‐penetrance genetic variants and clinical characteristics of Mediterranean melanoma families from the MelaNostrum Consortium.
Methods
Pooled epidemiological, clinical and genetic ( CDKN2A , CDK4 , ACD , BAP1 , POT1 , TERT , and TERF2IP and MC1R genes) retrospective data of melanoma families, collected within the MelaNostrum Consortium in Greece, Italy and Spain, were analysed. Univariate methods and multivariate logistic regression models were used to evaluate the association of variants with characteristics of families and of affected and unaffected family members. Subgroup analysis was performed for each country.
Results
We included 839 families (1365 affected members and 2123 unaffected individuals). Pathogenic/likely pathogenic CDKN2A variants were identified in 13.8% of families. The strongest predictors of melanoma were ≥2 multiple primary melanoma cases (OR 8.1; 95% CI 3.3–19.7), >3 affected members (OR 2.6; 95% CI 1.3–5.2) and occurrence of pancreatic cancer (OR 4.8; 95% CI 2.4–9.4) in the family (AUC 0.76, 95% CI 0.71–0.82). We observed low frequency variants in POT1 (3.8%), TERF2IP (2.5%), ACD (0.8%) and BAP1 (0.3%). MC1R common variants (≥2 variants and ≥2 RHC variants) were associated with melanoma risk (OR 1.4; 95% CI 1.0–2.0 and OR 4.3; 95% CI 1.2–14.6, respectively).
Conclusions
Variants in known high‐penetrance genes explain nearly 20% of melanoma familial aggregation in Mediterranean areas. CDKN2A melanoma predictors were identified with potential clinical relevance for cancer risk assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
- IRCCS Ospedale Policlinico San Martino, Genetica dei Tumori rari, Genoa, Italy.
- Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy.
- Department of Biochemistry and Molecular Genetics, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.
- Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.
- Biomedical Research Networking Center on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Barcelona, Spain.
ORCID-Profile: C Pellegrini, M Potrony, I Stefanaki, L Di Nardo, C Carrera, K Peris, E Nagore, S Puig, M C Fargnoli
Förderung
- NCI NIH HHS
- Intramural NIH HHS
- European Regional Development Fund
- Fundació la Marató de TV3
Zitieren
APA
Pellegrini, C., Cardelli, L., Ghiorzo, P., Pastorino, L., Potrony, M., García-Casado, Z., Elefanti, L., Stefanaki, I., Mastrangelo, M., Necozione, S., Aguilera, P., Rodríguez-Hernández, A., Di Nardo, L., Rocco, T., Del Regno, L., Badenas, C., Carrera, C., Malvehy, J., Requena, C., …, & Fargnoli, M. C. (2023). High‐ and intermediate‐risk susceptibility variants in melanoma families from the Mediterranean area: A multicentre cohort from the MelaNostrum Consortium. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.19461
Vancouver
Pellegrini C, Cardelli L, Ghiorzo P, Pastorino L, Potrony M, García-Casado Z, et al. High‐ and intermediate‐risk susceptibility variants in melanoma families from the Mediterranean area: A multicentre cohort from the MelaNostrum Consortium. Journal of the European Academy of Dermatology and Venereology. 2023. doi:10.1111/jdv.19461
BibTeX
@article{Pellegrini2023,
author = {Pellegrini, C and Cardelli, L and Ghiorzo, P and Pastorino, L and Potrony, M and García-Casado, Z and Elefanti, L and Stefanaki, I and Mastrangelo, M and Necozione, S and Aguilera, P and Rodríguez-Hernández, A and Di Nardo, L and Rocco, T and Del Regno, L and Badenas, C and Carrera, C and Malvehy, J and Requena, C and Bañuls, J and Stratigos, A J and Peris, K and Menin, C and Calista, D and Nagore, E and Puig, S and Landi, M T and Fargnoli, M C},
title = {High‐ and intermediate‐risk susceptibility variants in melanoma families from the Mediterranean area: A multicentre cohort from the MelaNostrum Consortium},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2023},
doi = {10.1111/jdv.19461}
}
EUVIMED